聚合内容 The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
更新时间: 7 分钟 10 秒 前

Firstkind Seeks Global Distribution Partners to Extend geko(TM) Device Roll-out

周三, 03/02/2016 - 13:29
LONDON, March 2, 2016 -- (Healthcare Sales & Marketing Network) -- The highly innovative UK based medical device company Firstkind Ltd, a subsidiary of Sky Medical Technology Ltd, is seeking to widen its network of global distribution partners to extend t...
Devices, Distribution
Firstkind Limited, Sky Medical Technology, geko device, DVT, electrostimulation

Merck KGaA, Darmstadt, Germany Initiates Phase III Study of MSB11022, a Proposed Biosimilar of Adalimumab, in Chronic Plaque Psoriasis

周三, 03/02/2016 - 13:20
First patient treated in global phase III clinical study AURIEL-Psoriasis Study will evaluate efficacy, safety and immunogenicity of adalimumab biosimilar candidate MSB11022 compared with Humira® DARMSTADT, Germany, March 2, 2016 -- (Healthcare S...
Biopharmaceuticals, Dermatology
Merck KGaA, adalimumab, biosimilar, MSB11022, plaque psoriasis, EMD Serono

FLAG Therapeutics Announces the Granting of Orphan Drug Designation to FLAG-003 in both the US and EU for the Treatment of Glioma

周二, 03/01/2016 - 16:41
RALEIGH, N.C., March 1, 2016 -- (Healthcare Sales & Marketing Network) -- FLAG Therapeutics Inc. announced today that the U.S. Food and Drug Administration's Office of Orphan Products Development and the European Medicines Agency (EMA) have both granted O...
Biopharmaceuticals, Oncology, FDA, Regulatory
FLAG Therapeutics, FLAG-003, glioma, glioblastoma

Mazor Robotics' Renaissance(R) Guidance System Achieves New Clinical Milestone

周二, 03/01/2016 - 16:39
ORLANDO, Fla., March 1, 2016 -- (Healthcare Sales & Marketing Network) -- Mazor Robotics (www.mazorrobotics.com), a pioneer in surgical guidance systems for spine and brain surgery, announced today a new clinical milestone with the successful completion of...
Devices, Neurosurgery
Mazor Robotics, Mazor Robotics Renaissance, robotic surgery

Leading BioSciences Expands Executive Leadership Team, Appoints Dr. Howard Dittrich as Chief Medical Advisor and Stephen Keane as Senior Vice President of Corporate Development

周二, 03/01/2016 - 16:36
Biotechnology Industry Leaders Join as Company Moves Forward With Novel Drug Candidate Targeting Mucosal Barrier Breakdown SAN DIEGO, March 1, 2016 -- (Healthcare Sales & Marketing Network) -- Leading BioSciences Inc., a clinical-stage biopharmaceutica...
Biopharmaceuticals, Personnel
Leading BioSciences

Savara Pharmaceuticals Completes $20 Million Round of Financing

周二, 03/01/2016 - 16:33
Preparation underway for Phase 3 trial of AeroVanc for MRSA lung infection in people with cystic fibrosis AUSTIN, Texas, March 1, 2016 -- (Healthcare Sales & Marketing Network) -- Savara Pharmaceuticals announced today that it has closed a $20 million ...
Biopharmaceuticals, Venture Capital
Savara Pharmaceuticals, AeroVanc, cystic fibrosis

Sotera Signs Agreement With Healthtrust For Wireless ViSi Mobile(R) System

周二, 03/01/2016 - 16:30
SAN DIEGO, March 1, 2016 -- (Healthcare Sales & Marketing Network) -- Sotera Wireless today announced that the company is now a contracted HealthTrust supplier in the wireless patient monitoring category. Under the agreement, HealthTrust member hospitals ...
Devices, Monitoring, Group Purchasing
Sotera Wireless, ViSi Mobile System, Vital Signs Monitor

Kreisers Awarded Major VA Contract

周二, 03/01/2016 - 16:28
SIOUX FALLS, S.D., March 1, 2016 -- (Healthcare Sales & Marketing Network) -- Kreisers, Inc. was recently awarded the Next Generation – Medical Surgical Prime Vendor (MSPV) contract to distribute medical/surgical supplies for The Department of Veterans Af...
Devices, Group Purchasing
Kreisers

Smith and Nephew Unveils its First 3D-Printed Titanium Hip Implant

周二, 03/01/2016 - 13:35
LONDON, March 1, 2016 -- (Healthcare Sales & Marketing Network) -- Smith & Nephew (NYSE:SNN; LSE:SN), the global medical technology business, is showcasing the new REDAPT™ Revision Acetabular Fully Porous Cup with CONCELOC™ Technology at this week's Ameri...
Devices, Orthopaedic, Product Launch
Smith & Nephew, REDAPT, CONCELOC, hip revision

Cook Group Incorporated Promotes Barry Slowey to President of Cook Endoscopy/Cook Winston-Salem

周二, 03/01/2016 - 13:25
BLOOMINGTON, Ind.--(Healthcare Sales & Marketing Network)--Cook Group is pleased to announce the promotion of Barry Slowey to president of Cook Endoscopy/Cook Winston-Salem. As president, Slowey will oversee the various functions in Winston-Salem, North Ca...
Devices, Personnel
Cook Medical, endoscopy, endoscope

Endocare Announces Signing Of Exclusive Agreement With R-Action Distribution

周二, 03/01/2016 - 13:15
AUSTIN, Texas and NYON, Switzerland, March 1, 2016 -- (Healthcare Sales & Marketing Network) -- Endocare, Inc announced today the signing of an exclusive agreement with R-Action Distribution Sàrl, a subsidiary of R-Action SAS, for the distribution ...
Devices, Oncology, Distribution
R-Action Distribution, Endocare, HealthTronics, cryoablation

New Elekta iViewDose Software Designed to Provide an Essential Safety Check for Radiation Therapy

周二, 03/01/2016 - 13:06
EPID-based in vivo patient dosimetry for error detection receives US FDA 510(k) clearance and CE Mark CRAWLEY, England, March 1, 2016 -- (Healthcare Sales & Marketing Network) -- The use of highly-focused, rapid delivery techniques such as intensity mo...
Devices, Oncology, Product Launch
Elekta, iViewDose, dosimetry, IMRT, VMAT, radiotherapy

Dentsply Sirona: Merger Creates The Dental Solutions Company(TM)

周一, 02/29/2016 - 20:11
YORK, Pennsylvania and SALZBURG, Austria, February 29, 2016 -- (Healthcare Sales & Marketing Network) -- Dentsply Sirona Inc. (XRAY) today announced that it has successfully completed the merger of equals between DENTSPLY International Inc. ("Dentspl...
Devices, Dental, Mergers & Acquisitions
Sirona Dental, DENTSPLY, Dentsply Sirona

Allergan Announces Receipt Of FDA Acceptable For Filing Letter For Generic XIFAXAN(R) ANDA

周一, 02/29/2016 - 20:08
DUBLIN, Feb. 29, 2016 -- (Healthcare Sales & Marketing Network) -- Allergan plc (AGN), a leading global pharmaceutical company, today announced that the Company has received an Acceptable for Filing letter from the U.S. Food and Drug Administration (FDA) ...
Biopharmaceuticals, Generics, Gastroenterology, FDA
Allergan, Valeant Pharmaceuticals, IFAXAN, rifaximin, irritable bowel syndrome

Asterias Biotherapeutics Appoints Stephen L. Cartt President and Chief Executive Officer

周一, 02/29/2016 - 13:51
Don M. Bailey Appointed to Board of Directors and Named Chairman FREMONT, Calif., Feb. 29, 2016 -- (Healthcare Sales & Marketing Network) -- Asterias Biotherapeutics, Inc. (NYSE MKT: AST) today announced the appointment of pharmaceutical industry veter...
Regenerative Medicine, Personnel
Asterias Biotherapeutics

Egalet Announces FDA Acceptance of New Drug Application for ARYMO(TM) ER (Morphine Sulfate) Extended-Release Tablets

周一, 02/29/2016 - 13:43
WAYNE, Pa., Feb. 29, 2016 -- (Healthcare Sales & Marketing Network) -- Egalet Corporation (EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and commercializing innovative treatments for p...
Biopharmaceuticals, Drug Delivery, FDA
Egalet Corp, ARYMO ER, morphine, Guardian Technology

CHMP Issues Positive Opinion for LONSURF(R) (trifluridine/tipiracil) for Refractory Metastatic Colorectal Cancer

周一, 02/29/2016 - 13:29
Recommendation is Based on RECOURSE Study Results Demonstrating Survival Advantage for Patients with Refractory Disease TOKYO, Feb. 29, 2016 -- (Healthcare Sales & Marketing Network) -- Taiho Pharmaceutical Co., Ltd. (Tokyo) today announced that the Co...
Biopharmaceuticals, Oncology, Regulatory
Taiho Pharmaceutical Co, LONSURF, metastatic colorectal cancer

Genentech Provides Update On Two Identical Phase III Studies Of Lebrikizumab In People With Severe Asthma

周一, 02/29/2016 - 13:20
One study met its primary endpoint, showing lebrikizumab significantly reduced exacerbations in people with severe asthma; the second study did not meet this primary endpoint Genentech continues to evaluate these study data to better understand the resu...
Biopharmaceuticals
Genentech, Roche Group, lebrikizumab, asthma

Galderma Delivers Innovation In Dermal Fillers With The Launch Of Two First-In-Class FDA Pivotal Phase III Trials

周五, 02/26/2016 - 15:01
Significant R&D Investments Support Fast-growing Restylane® Silk and Restylane® Lyft Dermal Filler Brands FORT WORTH, Texas, Feb. 26, 2016 -- (Healthcare Sales & Marketing Network) -- Galderma, a global leader focused on medical solutions in sk...
Biopharmaceuticals, Dermatology
Galderma, Restylane Silk, Restylane Lyft, Dermal Filler

Lilly Receives Positive CHMP Opinion for Ixekizumab for the Treatment of Moderate-to-Severe Plaque Psoriasis

周五, 02/26/2016 - 13:37
INDIANAPOLIS, Feb. 26, 2016 -- (Healthcare Sales & Marketing Network) -- Eli Lilly and Company (LLY) announced today that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for ixekizu...
Biopharmaceuticals, Regulatory
Eli Lilly, ixekizumab, plaque psoriasis

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong